European Respiratory Journal (ERJ) - Archive
 |
|
Published in the English language, the ERJ features:
- cutting edge clinical and experimental work in the field of respiratory medicine
- original articles
- series
- editorials
- correspondence
- short reports and case studies
All of which pertain the highest quality from professionals on a worldwide scale. The ERJ is the most highly regarded, peer reviewed, Respiratory Journal in Europe. |
| January (Issue 1 Volume 33) |  |
| The ERJ in its 21st year of age: a smooth transition for an everlasting evolution
Dinh-Xuan A. T., Brusasco V.
Eur Respir J 2009; 33: 1-2 |  |  | | | | | | | | | | | Safety of long-acting β-agonists: urgent need to clear the air remains
Beasley R., Martinez F. D., Hackshaw A., Rabe K. F., Sterk P. J., Djukanovic R.
Eur Respir J 2009; 33: 3-5 | | | | | | | | | | | | | Pulmonary infiltrates in patients with malignancies: why and how neutropenia influences clinical reasoning
Azoulay E.
Eur Respir J 2009; 33: 6-8 | | | | | | | | | | | | | From surgical to molecular scalpel: ERJ lung cancer series for 2009
Brambilla C.
Eur Respir J 2009; 33: 9-10 | | | | | | | | | | | | | Asthma therapy: how far have we come, why did we fail and where should we go next?
Janssen L. J.
Eur Respir J 2009; 33: 11-20 | | |  | | | | | | | | | | Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials
Sears M. R., Ottosson A., Radner F., Suissa S.
Eur Respir J 2009; 33: 21-32 | | | | | | | | | | | | | Dietary patterns and asthma in the E3N study
Varraso R., Kauffmann F., Leynaert B., Le Moual N., Boutron-Ruault M. C., Clavel-Chapelon F., Romieu I.
Eur Respir J 2009; 33: 33-41 | | | | | | | | | | | | | Cysteinyl leukotriene receptor 1 gene variation and risk of asthma
Hong X., Zhou H., Tsai H-J., Wang X., Liu X., Wang B., Xu X., Xu X.
Eur Respir J 2009; 33: 42-48 | | | | | | | | | | | | | Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients
Aliverti A., Quaranta M., Chakrabarti B., Albuquerque A. L. P., Calverley P. M.
Eur Respir J 2009; 33: 49-60 | | | | | | | | | | | | | Decreased FOXP3 expression in small airways of smokers with COPD
Isajevs S., Taivans I., Strazda G., Kopeika U., Bukovskis M., Gordjusina V., Kratovska A.
Eur Respir J 2009; 33: 61-67 | | | | | | | | | | | | | Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Park I. N., Jegal Y., Kim D. S., Do K-H., Yoo B., Shim T. S., Lim C-M., Lee S. D., Koh Y., Kim W. S., Kim W. D., Jang S. J., Kitaichi M., Nicholson A. G., Colby T. V.
Eur Respir J 2009; 33: 68-76 | | | | | | | | | | | | | MMP expression and abnormal lung permeability are important determinants of outcome in IPF
McKeown S., Richter A. G., O'Kane C., McAuley D. F., Thickett D. R.
Eur Respir J 2009; 33: 77-84 | | | | | | | | | | | | | Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study
van Gent M. W. F., Post M. C., Luermans J. G. L. M., Snijder R. J., Westermann C. J. J., Plokker H. W. M., Overtoom T. T., Mager J. J.
Eur Respir J 2009; 33: 85-91 | | | | | | | | | | | | | Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
Degano B., Yaici A., Le Pavec J., Savale L., Jais X., Camara B., Humbert M., Simonneau G., Sitbon O.
Eur Respir J 2009; 33: 92-98 | | | | | | | | | | | | | Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis
Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., Gosselink R., Decramer M., Dupont L.
Eur Respir J 2009; 33: 99-106 | | | | | | | | | | | | | Lung structure and function of infants with recurrent wheeze when asymptomatic
Llapur C. J., Martinez T. M., Coates C., Tiller C., Wiebke J. L., Li X., Applegate K., Coxson H. O., Tepper R. S.
Eur Respir J 2009; 33: 107-112 | | | | | | | | | | | | | Sniff nasal inspiratory pressure in children with muscular, chest wall or lung disease
Fauroux B., Aubertin G., Cohen E., Clement A., Lofaso F.
Eur Respir J 2009; 33: 113-117 | | | | | | | | | | | | | Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival
Ohri C. M., Shikotra A., Green R. H., Waller D. A., Bradding P.
Eur Respir J 2009; 33: 118-126 | | | | | | | | | | | | | Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
Mohamed S., Yasufuku K., Nakajima T., Hiroshima K., Chiyo M., Yoshida S., Suzuki M., Sekine Y., Shibuya K., Agamy G., El-Shahhat H., Fujisawa T., Yoshino I.
Eur Respir J 2009; 33: 127-133 | | | | | | | | | | | | | High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation
Sheen P., O'Kane C. M., Chaudhary K., Tovar M., Santillan C., Sosa J., Caviedes L., Gilman R. H., Stamp G., Friedland J. S.
Eur Respir J 2009; 33: 134-141 | | | | | | | | | | | | | The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia
Aliberti S., Myers J. A., Peyrani P., Blasi F., Menendez R., Rossi P., Cosentini R., Lopardo G., de Vedia L., Ramirez J. A.
Eur Respir J 2009; 33: 142-147 | | | | | | | | | | | | | Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
Santin M., Dorca J., Alcaide F., Gonzalez L., Casas S., Lopez M., Guerra M. R.
Eur Respir J 2009; 33: 148-152 | | | | | | | | | | | | | Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Restrepo M. I., Mortensen E. M., Waterer G. W., Wunderink R. G., Coalson J. J., Anzueto A.
Eur Respir J 2009; 33: 153-159 | | | | | | | | | | | | | Recurrence of tuberculosis in a low-incidence setting
Dobler C. C., Crawford A. B. H., Jelfs P. J., Gilbert G. L., Marks G. B.
Eur Respir J 2009; 33: 160-167 | | | | | | | | | | | | | CME | Reversing the tuberculosis upwards trend: a success story in Romania
Marica C., Didilescu C., Galie N., Chiotan D., Zellweger J. P., Sotgiu G., D'Ambrosio L., Centis R., Ditiu L., Migliori G. B.
Eur Respir J 2009; 33: 168-170 | | | | | | | | | | | | | Long-term macrolide therapy in chronic inflammatory airway diseases
Crosbie P. A. J., Woodhead M. A.
Eur Respir J 2009; 33: 171-181 | | | | | | | | | | | | | Animal models of ventilator-associated pneumonia
Luna C. M., Sibila O., Agusti C., Torres A.
Eur Respir J 2009; 33: 182-188 | | | | | | | | | | | | | Pulmonary veno-occlusive disease
Montani D., Price L. C., Dorfmuller P., Achouh L., Jais X., Yaici A., Sitbon O., Musset D., Simonneau G., Humbert M.
Eur Respir J 2009; 33: 189-200 | | | | | | | | | | | | | Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
De Wever W., Stroobants S., Coolen J., Verschakelen J. A.
Eur Respir J 2009; 33: 201-212 | | | | | | | | | | | | | Pulmonary veno-occlusive disease in myeloproliferative disorder
Willems E., Canivet J-L., Ghaye B., de Leval L., Radermecker M., Preiser J-C., Beguin Y.
Eur Respir J 2009; 33: 213-216 | | | | | | | | | | | | | Animal models of airway hyperresponsiveness
Said S. I.
Eur Respir J 2009; 33: 217-218 | | | | | | | | | | | | | Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study
Rage E., Siroux V., Le Moual N., Pin I., Kauffmann F.
Eur Respir J 2009; 33: 218-219 | | | | | | | | | | | | | Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema
Cottin V., Fabien N., Khouatra C., Moreira A., Cordier J-F.
Eur Respir J 2009; 33: 219-221 | | | | | | | | | | | | | Pre-immigration screening for pulmonary tuberculosis: the unanswered questions
Bhuniya S.
Eur Respir J 2009; 33: 221-222 | | | | | | | | | | | | | "CAN CAP GUIDELINE ADHERENCE IMPROVE PATIENT OUTCOME IN INTERNAL MEDICINE DEPARTMENTS?". F. BLASI, I. IORI, A. BULFONI, S. CORRAO, S. COSTANTINO AND D. LEGNANI. EUR RESPIR J 2008; 32: 902-910.
Eur Respir J 2009; 33: 223 | | | | | | | | | | | | | "THE LEICESTER COUGH MONITOR: A SEMI-AUTOMATED, SEMI-VALIDATED COUGH DETECTION SYSTEM?". S.S. BIRRING, V.M. MANN, S. MATOS, N. YOUSAF, C. WOOD, T. FLEMING, D.H. EVANS, A.H. MORICE AND I.D. PAVORD. EUR RESPIR J 2008; 32: 530-531.
Eur Respir J 2009; 33: 224 | | | | | | | | | | | | | Asthma
Gaga M.
Eur Respir J 2009; 33: 225 | | | | | | | | | | | |
|
|
WHAT YOU CAN FIND HERE  |
 |
Full text journal article |
 |
PDF journal article |
 |
Journal article abstract |
|
|